"2/ Many chronic diseases are caused by excessive proliferation or activity of specific cell populations
Arda’s hypothesis is that removing these cells, rather than simply modulating their dysfunction, will delay or reverse the progression of disease
3/ Cell elimination is a therapeutic strategy that has long been employed in oncology, but outside of oncology rather than removing harmful cells, most therapeutics modulate the activity of individual proteins with the goal of modifying cell behavior
4/ Two recent technology innovations have made cell clearance in chronic disease possible: 1) detailed cellular catalogs for most diseases and 2) easily programmable therapeutic tools to eliminate specific cells
5/ With a rare blend of expertise in pathological cell clearance, diseases of aging, computational biology and drug development, the Arda team, lead by founder and CEO @afreund83, is uniquely qualified to tackle this big opportunity
6/ Come build with us! Arda is looking for exceptional computational and experimental scientists who are excited to join our mission and reshape the treatment of chronic diseases and aging
2/ Biotech founders face a multitude of challenges in building their startup. How do you choose the best business model for your platform company? a16z.com/2021/01/08/bio…
3/ How do you choose the most impactful areas of application for your technology? a16z.com/2021/01/08/pla…